Evidence map›Paper›PMID 25123285›Full record

ReviewImmunological reviews2014

ID'ing innate and innate-like lymphoid cells.

Mihalis Verykokakis, Erin C Zook, Barbara L Kee

Abstract readReview
In one paragraph

Review in Immunological reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. The Function of E2A in B-Cell Development.Advances in experimental medicine and biology · 2024
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mihalis VerykokakisCommittee on Immunology and Department of Pathology, The University of Chicago, Chicago, IL, USA.
Erin C Zook
Barbara L Kee

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007090 · NIAID · UNIVERSITY OF CHICAGO · PI Peter Aidan Savage · 1985 to 2026
$11.7M
Transcriptional Control of Natural Killer Cell DevelopmentR01AI106352 · NIAID · UNIVERSITY OF CHICAGO · PI KEE, BARBARA L. · 2014 to 2023
$4.6M
Regulation of Lymphocyte Development by HLH ProteinsR01CA099978 · NCI · UNIVERSITY OF CHICAGO · PI KEE, BARBARA L. · 2003 to 2012
$3.2M
Transcriptional Control of HematopoiesisR01AI078267 · NIAID · UNIVERSITY OF CHICAGO · PI KEE, BARBARA L. · 2009 to 2013
$1.9M
E and Id protein function in natural killer T cell differentiationR56AI104303 · NIAID · UNIVERSITY OF CHICAGO · PI KEE, BARBARA L. · 2013 to 2013
$366k
Ets1Regulation of Natural Killer Cell Development and ActivationF32CA177235 · NCI · UNIVERSITY OF CHICAGO · PI ZOOK, ERIN CHRISTINE · 2013 to 2014
$99k
NCATS NIH HHS UL1 TR000430NCI NIH HHS CA099978NCI NIH HHS F32 CA177235NCI NIH HHS F32CA177235NCI NIH HHS R01 CA099978NIAID NIH HHS AI06352NIAID NIH HHS AI078267NIAID NIH HHS R01 AI078267NIAID NIH HHS R01 AI106352NIAID NIH HHS R56 AI104303NIAID NIH HHS T32 AI007090NIAID NIH HHS T32AI007090
6 · The paper itself

Abstract

The immune system can be divided into innate and adaptive components that differ in their rate and mode of cellular activation, with innate immune cells being the first responders to invading pathogens. Recent advances in the identification and characterization of innate lymphoid cells have revealed reiterative developmental programs that result in cells with effector fates that parallel those of adaptive lymphoid cells and are tailored to effectively eliminate a broad spectrum of pathogenic challenges. However, activation of these cells can also be associated with pathologies such as autoimmune disease. One major distinction between innate and adaptive immune system cells is the constitutive expression of ID proteins in the former and inducible expression in the latter. ID proteins function as antagonists of the E protein transcription factors that play critical roles in lymphoid specification as well as B- and T-lymphocyte development. In this review, we examine the transcriptional mechanisms controlling the development of innate lymphocytes, including natural killer cells and the recently identified innate lymphoid cells (ILC1, ILC2, and ILC3), and innate-like lymphocytes, including natural killer T cells, with an emphasis on the known requirements for the ID proteins.

Indexed as

Immunity, InnateAnimalsBasic Helix-Loop-Helix ProteinsB-LymphocytesCell LineageGene Expression RegulationHumansImmunologic MemoryKiller Cells, NaturalLymphocytesLymphopoiesisT-LymphocytesTranscriptomeBasic Helix-Loop-Helix ProteinsTCF3 protein, humancell differentiationnatural killer cellsnatural killer T cellsT-helper cellstranscription factors

Identifiers

PMID25123285
PMCPMC4159719

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.